Gabriel Cara Fuentes, MD, PhD
Assistant Professor, Pediatrics-Nephrology

Photo
Residency:
  • University of Florida Program, Pediatrics (2017)
Fellowships:
  • University of Florida Program, Pediatric Nephrology (2015)
Languages: English, Spanish
Department: Pediatrics-Nephrology

Professional Titles

  • Assistant Professor

Recognition & Awards

  • Career Development, Nephrotic Syndrome Study Network (NEPTUNE) (2021)
  • Faculty Award in Clinical Research, University of Michigan (2017)
  • Henry A. Kokomoor Award, University of Florida (2015)
  • Douglas J. Barrett Academic Fellowship Award, University of Florida (2014)

Publications

  • Wang CS, Smoyer WE, Cara-Fuentes G. Glomerular B7-1 staining: toward precision medicine for treatment of recurrent focal segmental glomerulosclerosis. Pediatr Nephrol. 2023 Jan;38(1):13-15. PubMed PMID: 35725967
  • Cara-Fuentes G, Andres-Hernando A, Bauer C, Banks M, Garcia GE, Cicerchi C, Kuwabara M, Shimada M, Johnson RJ, Lanaspa MA. Pulmonary surfactants and the respiratory-renal connection in steroid-sensitive nephrotic syndrome of childhood. iScience. 2022 Aug 19;25(8):104694. PubMed PMID: 35847557
  • Melena I, Piani F, Tommerdahl KL, Severn C, Chung LT, MacDonald A, Vinovskis C, Cherney D, Pyle L, Roncal-Jimenez CA, Lanaspa MA, Rewers A, van Raalte DH, Cara-Fuentes G, Parikh CR, Nelson RG, Pavkov ME, Nadeau KJ, Johnson RJ, Bjornstad P. Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study. J Diabetes Complications. 2022 Jun;36(6):108203. PubMed PMID: 35523653
  • Bauer C, Piani F, Banks M, Ordoñez FA, de Lucas-Collantes C, Oshima K, Schmidt EP, Zakharevich I, Segarra A, Martinez C, Roncal-Jimenez C, Satchell SC, Bjornstad P, Lucia MS, Blaine J, Thurman JM, Johnson RJ, Cara-Fuentes G. Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation. Kidney Int Rep. 2022 Apr;7(4):797-809. PubMed PMID: 35497798
  • Piani F, Sasai F, Bjornstad P, Borghi C, Yoshimura A, Sanchez-Lozada LG, Roncal-Jimenez C, Garcia GE, Hernando AA, Fuentes GC, Rodriguez-Iturbe B, Lanaspa MA, Johnson RJ. Hyperuricemia and chronic kidney disease: to treat or not to treat. J Bras Nefrol. 2021 Mar 5. [Epub ahead of print] PubMed PMID: 33704350
  • Piani F, Reinicke T, Borghi C, Tommerdahl KL, Cara-Fuentes G, Johnson RJ, Bjornstad P. Acute Kidney Injury in Pediatric Diabetic Kidney Disease. Front Pediatr. 2021;9:668033. PubMed PMID: 34211943
  • Cara-Fuentes G, Smoyer WE. Biomarkers in pediatric glomerulonephritis and nephrotic syndrome. Pediatr Nephrol. 2021 Jan 3. [Epub ahead of print] PubMed PMID: 33389089
  • Garcia GE, Lu YJ, Truong LD, Roncal-Jiménez CA, Miyazaki M, Miyazaki-Anzai S, Cara-Fuentes G, Andres-Hernando A, Lanaspa M, Johnson RJ, Leamon CP. A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats. Cells. 2021 Aug 17;10(8). PubMed PMID: 34440885
  • Takeuchi K, Ariyoshi Y, Shimizu A, Okumura Y, Cara-Fuentes G, Garcia GE, Pomposelli T, Watanabe H, Boyd L, Ekanayake-Alper DK, Amarnath D, Sykes M, Sachs DH, Johnson RJ, Yamada K. Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation. Xenotransplantation. 2021 Nov;28(6):e12708. PubMed PMID: 34418164
  • Piani F, Reinicke T, Borghi C, Tommerdahl KL, Cara-Fuentes G, Johnson RJ, Bjornstad P. Acute Kidney Injury in Pediatric Diabetic Kidney Disease. Front Pediatr. 2021;9:668033. PubMed PMID: 34211943
  • Piani F, Sasai F, Bjornstad P, Borghi C, Yoshimura A, Sanchez-Lozada LG, Roncal-Jimenez C, Garcia GE, Hernando AA, Fuentes GC, Rodriguez-Iturbe B, Lanaspa MA, Johnson RJ. Hyperuricemia and chronic kidney disease: to treat or not to treat. J Bras Nefrol. 2021 Oct-Dec;43(4):572-579. PubMed PMID: 33704350
  • Cara-Fuentes G, Smoyer WE. Biomarkers in pediatric glomerulonephritis and nephrotic syndrome. Pediatr Nephrol. 2021 Sep;36(9):2659-2673. PubMed PMID: 33389089
  • Cara-Fuentes G, Venkatareddy M, Verma R, Segarra A, Cleuren AC, Martínez-Ramos A, Johnson RJ, Garg P. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse. Pediatr Nephrol. 2020 Oct;35(10):1887-1896. PubMed PMID: 32399663
  • Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, Borghi C, Piani F, Cara-Fuentes G, Bjornstad P, Lanaspa MA, Johnson RJ. Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020 Jul 18;33(7):583-594. PubMed PMID: 32179896
  • Isom R, Shoor S, Higgins J, Cara-Fuentes G, Johnson RJ. Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria. Kidney Int Rep. 2019 Sep;4(9):1349-1353. PubMed PMID: 31517155
  • Cara-Fuentes G, Lanaspa MA, Garcia GE, Banks M, Garin EH, Johnson RJ. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease. Pediatr Nephrol. 2018 Jul;33(7):1101-1103. PubMed PMID: 29492674
  • Verma R, Venkatareddy M, Kalinowski A, Li T, Kukla J, Mollin A, Cara-Fuentes G, Patel SR, Garg P. Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus. PLoS One. 2018;13(6):e0198013. PubMed PMID: 29924795
  • Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series. Am J Kidney Dis. 2017 Dec;70(6):834-843. PubMed PMID: 28838767
  • Cara-Fuentes G, Segarra A, Silva-Sanchez C, Wang H, Lanaspa MA, Johnson RJ, Garin EH. Angiopoietin-like-4 and minimal change disease. PLoS One. 2017;12(4):e0176198. PubMed PMID: 28441404
  • Cara-Fuentes G, Clapp WL, Johnson RJ, Garin EH. Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms. Pediatr Nephrol. 2016 Dec;31(12):2179-2189. PubMed PMID: 27384691
  • Cara-Fuentes G, Gupta N, Garin EH. The RIVUR study: a review of its findings. Pediatr Nephrol. 2015 May;30(5):703-6. PubMed PMID: 25503325
  • Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol. 2015 Mar;30(3):469-77. PubMed PMID: 25239302
  • Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?. Pediatr Nephrol. 2014 Dec;29(12):2333-40. PubMed PMID: 25017621
  • Cara-Fuentes G, Johnson RJ, Reiser J, Garin EH. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response. Pediatr Nephrol. 2014 Aug;29(8):1467-8. PubMed PMID: 24817342
  • Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol. 2014 Aug;29(8):1363-71. PubMed PMID: 24263531
  • Cara-Fuentes G, Kairalla JA, Ishimoto T, Rivard C, Johnson RJ, Garin EH. Rituximab in idiopathic nephrotic syndrome: does it make sense?. Pediatr Nephrol. 2014 Aug;29(8):1313-9. PubMed PMID: 23793923
  • Ishimoto T, Cara-Fuentes G, Wang H, Shimada M, Wasserfall CH, Winter WE, Rivard CJ, Araya CE, Saleem MA, Mathieson PW, Johnson RJ, Garin EH. Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes. Pediatr Nephrol. 2013 Sep;28(9):1803-12. PubMed PMID: 23689904
  • Cara-Fuentes G, Araya C, Wei C, Rivard C, Ishimoto T, Reiser J, Johnson RJ, Garin EH. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation. Nefrologia. 2013;33(5):727-31. PubMed PMID: 24089165
  • Cara Fuentes GM, Espinosa Roman L, Melgosa Hijosa M, Navarro Torres M. Acute renal failure due to bilateral pieloureteral stone impaction in a 10-month-old boy. Clin Exp Nephrol. 2010 Aug;14(4):401-3. PubMed PMID: 20464442
  • Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA, Torres MN. Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Pediatr Nephrol. 2010 Mar;25(3):529-34. PubMed PMID: 19956977
View All (30 Total) View Less

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Specialty Information

Specialties
  • Pediatric Nephrology, Board Certification
Conditions & Treatments
  • Kidneys and Urinary System - Nephrotic Syndrome
  • Kidneys and Urinary System
  • Kidneys and Urinary System - Proteinuria
  • Kidneys and Urinary System - Kidney Disease
Clinical Interests
Nephrotic syndrome, minimal change disease, focal segmental glomerulosclerosis, glomerular disease

Public Speaking
Yes

General Information

Residency Programs:
  • University of Florida Program, Pediatrics (2017)
Fellowships:
  • University of Florida Program, Pediatric Nephrology (2015)
Languages: English, Spanish
Department: Pediatrics-Nephrology
SOM Resources
CU Resources
Contact Us
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;